LIV Emles at Home ETF

Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and The Samaritan Innovative Science Foundation (The Samaritan Foundation), a 501 (c)(3) nonprofit supported by Samaritan, announced today it is developing a CSI BioFuture (Science Laboratory) BioBus that could be key to keeping American innovation alive in our children. Why a science bus? The February 13, 2006 edition of Time Magazine asks, Is America Flunking Science?...the consensus of this article is that science education in the U.S. is slowing down while other countries are speeding up in science and technology. About one-third of all jobs in the U.S. require science or technology competency, but currently only 17% of our students graduate with such degrees, according to recent studies by the Council of Competitiveness. By contrast, the world's average is 27%, and in China, 51% of college degrees awarded, are in science and technology. BioFuture, a first of its kind, is an innovative science laboratory, placed on a 40-foot touring vehicle passenger's bus. The experiential curriculum based on the popular CSI (Criminal Science Investigation), we think will bring a more interesting venue to science for the seventh through twelfth grader. We envision involving students in solving scientific mysteries, as well, as being mystified with their own DNA. Dianne Thompson, SVP of the Samaritan Foundation stated, "As soon as we raise the $1 million dollars necessary to get BioFuture on the road, we can get it cruising in Las Vegas. Please contact me, if you can help. The kids and I will be forever grateful." About Samaritan Pharmaceuticals Samaritan Pharmaceuticals is a drug development company driven to discover, develop and commercialize innovative therapeutics for AIDS, cancer and Alzheimer's and heart diseases. Samaritan, in collaboration with Georgetown University, is advancing eight promising compounds out of its rich pipeline of 250 possible drug candidates, all of which have the potential to create revenue-generating opportunities. For additional information, visit www.samaritanpharma.com. About The Samaritan Innovative Science Foundation The Samaritan Innovative Science Foundation (The Samaritan Foundation) is a 501(C)(3) nonprofit organization founded in 2003 by Dr. Janet Greeson, CEO, and Eugene Boyle, CFO of Samaritan Pharmaceuticals (AMEX:LIV). The Foundation's focus and passion is to meet the unmet medical and social needs of children. For additional information, visit www.samaritanpharma.org.